Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 23Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Multiple Myeloma 7Recurrence 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Mantle-Cell 3Lymphoma, Follicular 2Lymphoma 2Tumor Lysis Syndrome 1Thromboembolism 1Teratogenesis 1Sleepiness 1Seizures 1Renal Insufficiency 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Peripheral Nervous System Diseases 1Neoplasms, Second Primary 1Neoplasms, Plasma Cell 1Neoplasms 1Myelodysplastic Syndromes 1Lung Diseases, Interstitial 1Infections 1Hypothyroidism 1Hypotension, Orthostatic 1Hypersensitivity 1Hemorrhage 1Heart Failure 1Fatigue 1Dizziness 1Digestive System Diseases 1Coronary Artery Disease 1Confusion 1

Interventions

Surveys and Questionnaires 86Blood Specimen Collection 58Interviews as Topic 28Observation 15Data Collection 15Radiotherapy 12Watchful Waiting 11Magnetic Resonance Spectroscopy 11Hematologic Tests 11Exercise 11Drug Therapy 11Quality of Life 9Biopsy 8Specimen Handling 7Therapeutics 6Restraint, Physical 6Magnetic Resonance Imaging 6Focus Groups 6pembrolizumab 5Standard of Care 5Rivaroxaban 5Phlebotomy 5Nivolumab 5Lapatinib 5Immune Checkpoint Inhibitors 5atezolizumab 4apixaban 4Trastuzumab 4Patient Reported Outcome Measures 4Palliative Care 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Neoplasms × Lenalidomide × Clear all
NCT06251648 2024-02-09

Acute Lymphoblastic Leukaemia Related to Lenalidomide (LenALL)

University Hospital, Caen

Unknown
300 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡